1-3 of 3
Original Paper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Elevated TNIP3 mRNA Expression in TNF-α-Secreting Cells from Patients with Major Depressive Disorder

Subject Area:
Topic Article Package: Moksha , Endocrinology , Immunology and Allergy , Neurology and Neuroscience
Kai-Wei Huang, Ming-Kung Wu, Yi-Yung Hung
Journal: Neuroimmunomodulation
Neuroimmunomodulation (2019) 26 (3): 153–158.
https://doi.org/10.1159/000501083
Published Online: 15 July 2019
View articletitled, Elevated TNIP3 mRNA Expression in TNF-α-Secreting Cells from Patients with Major Depressive Disorder
Open the PDF for Elevated TNIP3 mRNA Expression in TNF-α-Secreting Cells from Patients with Major Depressive Disorder in another window
Journal Articles

Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder

Subject Area:
Endocrinology , Immunology and Allergy , Neurology and Neuroscience
Baozhu Liu, Xiaonan Zhong, Zhengqi Lu, Wei Qiu, Xueqiang Hu, Honghao Wang
Journal: Neuroimmunomodulation
Neuroimmunomodulation (2019) 25 (4): 185–192.
https://doi.org/10.1159/000489561
Published Online: 13 November 2018
View articletitled, Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder
Open the PDF for Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder in another window
Journal Articles

GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease

Subject Area:
Endocrinology , Immunology and Allergy , Neurology and Neuroscience
Jing Guan, Beibei Yang, Yi Fan, Ji Zhang
Journal: Neuroimmunomodulation
Neuroimmunomodulation (2017) 24 (1): 60–66.
https://doi.org/10.1159/000478908
Published Online: 16 August 2017
View articletitled, GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease
Open the PDF for GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease in another window